The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

42 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and T-type calcium channel-blocking effects of aryl(1,5-disubstituted-pyrazol-3-yl)methyl sulfonamides for neuropathic pain treatment.EBI
Korea Institute of Science & Technology (Kist)
Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers.EBI
Actelion Pharmaceuticals
Preparation, Antiepileptic Activity, and Cardiovascular Safety of Dihydropyrazoles as Brain-Penetrant T-Type Calcium Channel Blockers.EBI
Actelion Pharmaceuticals
3-Benzamides and 3,4,5-trimethoxyphenyl amines as calcium channel blockers.EBI
Ewha Womans University
Inhibition of cellular proliferation and induction of apoptosis in human lung adenocarcinoma A549 cells by T-type calcium channel antagonist.EBI
Kyung Hee University
Synthesis and biological evaluation of 1-(2-hydroxy-3-phenyloxypropyl)piperazine derivatives as T-type calcium channel blockers.EBI
Korea Institute of Science and Technology
3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).EBI
Kyung Hee University
Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers.EBI
Institute of Science and Technology
Quinazolindione derivatives as potent 5-HT3A receptor antagonists.EBI
Konkuk University
Design, synthesis, and biological evaluation of 1,3-dioxoisoindoline-5-carboxamide derivatives as T-type calcium channel blockers.EBI
Institute of Science and Technology
Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers.EBI
Korea Institute of Science & Technology
In vivo evaluation of oral anti-tumoral effect of 3,4-dihydroquinazoline derivative on solid tumor.EBI
Kyung Hee University
Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.EBI
Korea Institute of Science and Technology
Synthesis and pharmacological evaluation of 1-alkyl-N-[2-ethyl-2-(4-fluorophenyl)butyl]piperidine-4-carboxamide derivatives as novel antihypertensive agents.EBI
Astellas Pharma
Pyridyl amides as potent inhibitors of T-type calcium channels.EBI
Merck Research Laboratories
Facile synthesis and biological evaluation of 3,3-diphenylpropanoyl piperazines as T-type calcium channel blockers.EBI
Institute of Science and Technology
Synthesis and T-type calcium channel blocking activity of novel diphenylpiperazine compounds, and evaluation of in vivo analgesic activity.EBI
Ewha Womans University
Synthesis and biological evaluation of 1,4-diazepane derivatives as T-type calcium channel blockers.EBI
Institute of Science and Technology
Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.EBI
Merck Research Laboratories
Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.EBI
Institute of Science and Technology
T-type Ca2+ channel blockers suppress the growth of human cancer cells.EBI
Kyung Hee University
Discovery of potent T-type calcium channel blocker.EBI
Kyung Hee University
Lead discovery and optimization of T-type calcium channel blockers.EBI
Institute of Science and Technology
3D pharmacophore based virtual screening of T-type calcium channel blockers.EBI
Institute of Science and Technology
Synthesis and biological evaluation of novel T-type calcium channel blockers.EBI
Kyung Hee University
Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.EBI
Institute of Science and Technology
Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers.EBI
Institute of Science and Technology
Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification.EBI
Zhejiang University
3,4-Dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers.EBI
Institute of Science & Technology
In vitro synergistic anticancer activity of the combination of T-type calcium channel blocker and chemotherapeutic agent in A549 cells.EBI
Kyung Hee University
Synthesis and cytotoxic effects of 2-thio-3,4-dihydroquinazoline derivatives as novel T-type calcium channel blockers.EBI
Kyung Hee University
Synthesis and evaluation of 6-pyrazoylamido-3N-substituted azabicyclo[3,1,0]hexane derivatives as T-type calcium channel inhibitors for treatment of neuropathic pain.EBI
Korea Institute of Science & Technology (Kist)
Structural hybridization of pyrrolidine-based T-type calcium channel inhibitors and exploration of their analgesic effects in a neuropathic pain model.EBI
Korea Institute of Science and Technology
Congenetic Hybrids Derived from Dearomatized Isoprenylated Acylphloroglucinol with Opposite Effects on CaEBI
Chinese Academy of Sciences
The discovery and optimization of benzimidazoles as selective NaEBI
Pfizer
Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker.EBI
The Catholic University of Korea
In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers.EBI
Kyung Hee University
Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers.EBI
University of Toyama
Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies.EBI
Idorsia Pharmaceuticals
Discovery and evaluation of CaEBI
Idorsia Pharmaceuticals
Discovery and evaluation of CaEBI
Idorsia Pharmaceuticals
A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance.BDB
The Johns Hopkins University